Jake Jorgovan
NOVEMBER 15, 2023
If you’re in the BioPharma and Pharmaceutical industries, your most valuable resource isn’t just the latest breakthrough drug or cutting-edge technology. Enter the world of executive search firms, headhunters, and recruiters specializing in the BioPharma and Pharmaceutical industries. Let’s dive in.
Jake Jorgovan
NOVEMBER 15, 2023
Their focus on values and work ethics makes them a standout partner in the pursuit of top CRO talent. With expertise in connecting organizations with top-tier executive talent, "Alliance International Services" is a trusted partner for businesses seeking CROs who can drive success in today's competitive landscape.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Jake Jorgovan
APRIL 25, 2024
Since its establishment, Proclinical Executive has focused exclusively on the life sciences sector, including biopharma, medical devices, and digital health. The firm is dedicated to securing senior leadership and C-suite positions, leveraging a deep understanding of the life sciences industry to match companies with top executive talent.
Jake Jorgovan
FEBRUARY 1, 2024
Manage construction projects, leveraging decades of experience in project management. Why work with Eradigm Consulting: Eradigm Consulting's approach is driven by a passion for high performance and delivering excellence in the biopharma industry. Focus on emerging trends such as digital innovation and the evolving market in China.
Jake Jorgovan
NOVEMBER 27, 2023
Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A). Their services are utilized across multiple industries including construction, banking, retail, education, and healthcare.
Frost & Sullivan
MAY 12, 2021
A rise in new disease outbreaks, the urgency to launch innovative therapies, and new constructs such as multi-valent antibodies are compelling biopharmaceutical companies to adopt new manufacturing approaches. . – May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times.
LaVoie Health Science Blog
JULY 16, 2021
According to Moody’s , “investors and asset managers now have a keener focus on ESG investment themes, ESG data and the incorporation of ESG considerations in investment analysis and product construction.” What are some of the unique considerations that biopharma and life science firms must consider in mapping out their ESG strategies?
Expert insights. Personalized for you.
130 
Let's personalize your content